Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals are plunging again after its CEO was subpoenaed by a congressional committee.
Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals are plunging again after its CEO was subpoenaed by a congressional committee.
0 commentaires:
Enregistrer un commentaire